| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRUROL.2017.125 |
| P698 | PubMed publication ID | 28895563 |
| P50 | author | Shahrokh Shariat | Q7462263 |
| David D'Andrea | Q49486914 | ||
| Francesco Soria | Q89184322 | ||
| Eva Compérat | Q90142190 | ||
| Stephan M Korn | Q114404156 | ||
| Marco Moschini | Q39051563 | ||
| P2093 | author name string | Yasin Irmak | |
| P2860 | cites work | A rare bladder cancer--small cell carcinoma: review and update | Q21202862 |
| Sarcomatoid Carcinoma of the Urinary Bladder | Q30251645 | ||
| Refining patient selection for neoadjuvant chemotherapy before radical cystectomy | Q30408866 | ||
| Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data | Q30619218 | ||
| Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer | Q30713680 | ||
| Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib | Q34028470 | ||
| Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases | Q34035325 | ||
| Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases | Q34138387 | ||
| Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer | Q34226107 | ||
| Sarcomatoid carcinoma of the urinary bladder: a clinicopathological study of 4 cases and a review of the literature | Q34239041 | ||
| The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis | Q34285407 | ||
| Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis | Q34570737 | ||
| Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases | Q34572023 | ||
| Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. | Q34581376 | ||
| Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients | Q34738811 | ||
| The changing patterns of bladder cancer in Egypt over the past 26 years | Q34763192 | ||
| Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma | Q47977800 | ||
| The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours | Q48844213 | ||
| Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm? | Q50666101 | ||
| Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes. | Q50716343 | ||
| The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity? | Q51064538 | ||
| Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. | Q51495764 | ||
| Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. | Q51611422 | ||
| Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. | Q51726252 | ||
| The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. | Q51819769 | ||
| Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy. | Q53035018 | ||
| Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. | Q53377752 | ||
| Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. | Q53495378 | ||
| Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. | Q53569362 | ||
| Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain. | Q53589979 | ||
| Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. | Q54399364 | ||
| HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. | Q54594744 | ||
| E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma | Q54762904 | ||
| Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens | Q57582151 | ||
| Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis | Q59649540 | ||
| Adenocarcinoma Versus Urothelial Carcinoma of the Urinary Bladder: Comparison Between Pathologic Stage at Radical Cystectomy and Cancer-specific Mortality | Q59649561 | ||
| Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder | Q68389725 | ||
| Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases | Q69595003 | ||
| Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions | Q71835149 | ||
| Lymphoepithelioma-like carcinoma of the urinary bladder | Q72395708 | ||
| Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma | Q72850970 | ||
| Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. | Q45905367 | ||
| A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. | Q45983103 | ||
| A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma. | Q46033801 | ||
| Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience | Q46737967 | ||
| Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread. | Q46831528 | ||
| Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant | Q73477196 | ||
| Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases | Q73733130 | ||
| In situ adenocarcinoma of the bladder | Q74071912 | ||
| Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases | Q74255273 | ||
| Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder | Q77950655 | ||
| Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients | Q80493136 | ||
| Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection | Q80682537 | ||
| Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases | Q81288987 | ||
| Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder | Q81441276 | ||
| Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients | Q82268241 | ||
| Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis | Q82820993 | ||
| Clear cell carcinoma of the bladder in a patient with a earlier clear cell renal cell carcinoma: a case report with morphologic, immunohistochemical, and cytogenetical analysis | Q83162334 | ||
| Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? | Q83296498 | ||
| Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series | Q83445851 | ||
| Plasmacytoid urothelial carcinoma of the bladder | Q83500443 | ||
| Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases | Q83825481 | ||
| Multiple adverse histological features increase the odds of under staging T1 bladder cancer | Q83843138 | ||
| Pleomorphic giant cell carcinoma of the urinary bladder | Q83903257 | ||
| The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma | Q84389717 | ||
| Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? | Q84795217 | ||
| The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy | Q85240152 | ||
| Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis | Q85409274 | ||
| Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer | Q86065511 | ||
| A case of urothelial carcinoma, lipid cell variant | Q86492191 | ||
| Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour | Q86918675 | ||
| EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 | Q87711943 | ||
| Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder | Q87986617 | ||
| International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial | Q35023400 | ||
| A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma | Q35032038 | ||
| Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) | Q35051123 | ||
| Is radical cystectomy mandatory in every patient with variant histology of bladder cancer | Q35093233 | ||
| Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy. | Q35663298 | ||
| Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder | Q35737362 | ||
| Small cell carcinoma of the bladder | Q35817160 | ||
| Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. | Q35833326 | ||
| Non-transitional cell bladder carcinomas | Q36037516 | ||
| Clinical outcomes of cT1 micropapillary bladder cancer | Q36393891 | ||
| Micropapillary bladder cancer: current treatment patterns and review of the literature. | Q36393900 | ||
| Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications | Q36584304 | ||
| Primary Signet-Ring Cell Carcinoma of the Urinary Bladder | Q36618138 | ||
| The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer | Q36685786 | ||
| HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder | Q36724623 | ||
| Nonurothelial cancer of the bladder | Q36729158 | ||
| Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients | Q36836840 | ||
| Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database | Q36845510 | ||
| Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience | Q36871918 | ||
| Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer | Q36934369 | ||
| Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. | Q36953757 | ||
| Primary Clear Cell Carcinoma of the Urinary Bladder | Q36979585 | ||
| The impact of variant histology on the outcome of bladder cancer treated with curative intent | Q37119414 | ||
| Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. | Q37274315 | ||
| Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network | Q37348345 | ||
| Clear cell adenocarcinoma of the urinary bladder: a short review | Q37506485 | ||
| Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications | Q37507542 | ||
| Micropapillary Bladder Cancer: Insights from the National Cancer Database | Q37530374 | ||
| Emerging concepts in micropapillary urothelial carcinoma | Q37737010 | ||
| Glandular lesions of the urinary bladder:clinical significance and differential diagnosis | Q37790432 | ||
| Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder | Q37836129 | ||
| Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation | Q37864897 | ||
| Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma | Q37916149 | ||
| Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options | Q37985853 | ||
| Imaging features of common and uncommon bladder neoplasms | Q38002241 | ||
| Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital | Q38011384 | ||
| Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy | Q38090151 | ||
| EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. | Q38119345 | ||
| Should histologic variants alter definitive treatment of bladder cancer? | Q38123651 | ||
| Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. | Q38155748 | ||
| Sarcomatoid variant of urothelial carcinoma of the urinary bladder | Q38187305 | ||
| Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology | Q38232295 | ||
| Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection | Q38232671 | ||
| Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy | Q38245360 | ||
| Contemporary bladder cancer: variant histology may be a significant driver of disease. | Q38280314 | ||
| Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study. | Q38390445 | ||
| Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline | Q38689374 | ||
| Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012). | Q38741943 | ||
| The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours | Q38758269 | ||
| Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. | Q38792051 | ||
| Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer. | Q38800577 | ||
| The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-M | Q38818480 | ||
| Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. | Q38893600 | ||
| Primary adenocarcinoma of the urinary bladder: a report of 185 cases. | Q38988676 | ||
| Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy | Q39021486 | ||
| Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients | Q39046515 | ||
| Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade | Q39424785 | ||
| Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists | Q39946355 | ||
| Small cell carcinoma of the bladder and prostate | Q40379901 | ||
| Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. | Q40668752 | ||
| Outcomes of squamous histology in bladder cancer: a population-based study | Q40710299 | ||
| HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC). | Q40713928 | ||
| Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. | Q40842208 | ||
| Pleomorphic lymphoepithelioma-like carcinoma of the urinary bladder. | Q41869504 | ||
| Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer | Q42480844 | ||
| Income inequality and treatment of African American men with high-risk prostate cancer | Q43533141 | ||
| Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases | Q43579953 | ||
| A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder | Q43668544 | ||
| Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases | Q44062304 | ||
| Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases | Q44271939 | ||
| Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database | Q44686022 | ||
| Carcinosarcoma of the urinary bladder following cyclophosphamide therapy: evidence for monoclonal origin and chromosome 9p allelic loss | Q44704309 | ||
| Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder | Q44836523 | ||
| Small cell carcinoma of the urinary bladder. The Mayo Clinic experience | Q45077919 | ||
| Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry | Q45755615 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 651-668 | |
| P577 | publication date | 2017-09-12 | |
| P1433 | published in | Nature Reviews Urology | Q2079265 |
| P1476 | title | Characteristics and clinical significance of histological variants of bladder cancer | |
| P478 | volume | 14 |
| Q58614974 | A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease |
| Q90600334 | A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma |
| Q52673351 | Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. |
| Q92487447 | Adjuvant chemotherapy in bladder cancer patients with histological variants: time to change the approach? |
| Q97550200 | Bladder cancer incidence rates and trends in young adults aged 20-39 years |
| Q64260278 | CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer |
| Q60918065 | Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter |
| Q89665220 | Genomic profiling suggests possible immunotherapy response in rare subtypes |
| Q64262728 | Histological variants in non-muscle invasive bladder cancer |
| Q90941487 | Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? |
| Q98771470 | Mechanisms of Macrophage Immunomodulatory Activity Induced by a New Polysaccharide Isolated From Polyporus umbellatus (Pers.) Fries |
| Q91755063 | Molecular and histopathology directed therapy for advanced bladder cancer |
| Q88673185 | Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort |
| Q90129680 | Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? |
| Q55404892 | Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data. |
| Q93128449 | Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer |
| Q55263257 | Prognostication in Patients Treated with Radical Cystectomy for Urothelial Bladder Carcinoma: A New Simplified Model Incorporating Histological Variants. |
| Q90662495 | Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype |
| Q57464869 | T1 bladder cancer: current considerations for diagnosis and management |
| Q57063454 | The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer |
| Q64262721 | The need to improve TURB: a diagnostic and therapeutic fundamental first step in the disease's management |
| Q90627464 | The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC) |
| Q64262714 | The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer |
| Q91776606 | Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy |
Search more.